Omontys Recall Issued by Manufacturer

Last Updated on January 11, 2022

Important Information

Attorneys working with are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.

Comments |

At A Glance

This Alert Affects
Kidney dialysis patients who have been administered the drug Omontys.
Anaphylaxis, serious allergic reactions, death.
Affymax Inc. and Takeda
Additional Details
Omontys treats anemia in kidney dialysis patients.
On February 24, 2013, Takeda and Affymax announced a recall on all lots of Omontys.